ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.

Mensali N, Koksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fane A, Ramirez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland OS, Menendez P, Inderberg EM, Walchli S
Nat Commun. 2023 Jun 8;14(1):3375. doi: 10.1038/s41467-023-39097-x. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.